Please provide your email address to receive an email when new articles are posted on . A 42-year-old man with no significant medical history presented initially in the emergency department of an ...

Please provide your email address to receive an email when new articles are posted on . A 69-year-old retired radio host and disc jockey was referred to the neuro-ophthalmology service for evaluation ...

SAN DIEGO — Double vision is the predominant symptom in more than half of patients with moderate to severe Graves' orbitopathy; however, the symptom negatively correlates with inflammation and in fact ...

Elegrobart is a subcutaneously-administered monoclonal antibody designed to target and inhibit the IGF-1 receptor, a key driver of thyroid eye disease.

Viridian Therapeutics has announced encouraging topline results from its REVEAL‑1 phase 3 clinical trial evaluating ...